Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa TherapyRichard Gray, Carl Counsell, Natalie Ives et al.|JAMA Neurology|2021Cited by 61